The treatment of cancer with proton radiation therapy was first suggested in 1946 followed
by the first treatments in the 1950s. As of 2020, almost 200 000 patients have been treated …

Precision medicine relies on an increasing amount of heterogeneous data. Advances in
radiation oncology, through the use of CT Scan, dosimetry and imaging performed before …

The Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) review
summarizes the currently available three-dimensional dose/volume/outcome data to update …

Artificial intelligence (AI) is emerging as a technology with the power to transform
established industries, and with applications from automated manufacturing to advertising …

Advances in dose–volume/outcome (or normal tissue complication probability, NTCP)
modeling since the seminal Emami paper from 1991 are reviewed. There has been some …

We have reviewed the published data regarding radiotherapy (RT)-induced brain injury.
Radiation necrosis appears a median of 1–2 years after RT; however, cognitive decline …

Radiation oncology has always been deeply rooted in modeling, from the early days of
isoeffect curves to the contemporary Quantitative Analysis of Normal Tissue Effects in the …

Accumulating evidence suggests that characteristics of pre-treatment FDG–PET could be
used as prognostic factors to predict outcomes in different cancer sites. Current risk analyses …

BACKGROUND AND PURPOSE: The purpose of this large multicentre prospective cohort
study was to identify which dose volume histogram parameters and pre-treatment factors are …

Publications relating esophageal radiation toxicity to clinical variables and to quantitative
dose and dose–volume measures derived from three-dimensional conformal radiotherapy …